Oral Abstract Session:
181. Challenges in C. difficile Infection Surveillance
Saturday, October 20, 2012: 10:30 AM-12:00 PM
Room: SDCC 29 ABCD

Learning Objectives:

-

Target Audience: Academicians

Topical Category: N. Infection Epidemiology and Prevention

Tracks: Epidemiology and Infection Control, Investigative ID, HIV-STD-TB

Moderators:  Erik Dubberke, MD, MSPh, Washington University School of Medicine and Karen Carroll, MD, FIDSA, John Hopkins University School of Medicine

Presentations:

10:30 AM
Risk Adjustment for Healthcare Facility-Onset C. difficile Infection and MRSA Bacteremia Reporting in NHSN
Maggie Dudeck, MPH, CPH ; Paul Malpiedi, MPH ; Jonathan Edwards, MStat ; Scott Fridkin, MD, FSHEA ; L. Clifford Mcdonald, MD ; Dawn Sievert, PhD

10:45 AM
Defining “Nosocomial” – Differences in MDRO and C. difficile Rates Using 2-Day vs. 3-Day Definitions
Adrijana Gombosev, BS ; Salah Fouad, MS ; Eric Cui, BS ; Leah Terpstra, BA ; Diane Kim, BS ; Hildy Meyers, MD MPH ; Michele Cheung, MD MPH ; Susan S. Huang, MD, MPH, FIDSA

11:00 AM
Evaluation of Differences in Population-Based Incidence of Clostridium difficile Infection across Diverse U.S. Geographic Locations, 2010
Fernanda Lessa, MD ; Yi Mu, PhD ; Jessica Cohen, MPH ; Ghinwa Dumyati, MD, FSHEA ; Monica M. Farley, MD ; Lisa Winston, MD ; Kelly Kast, MPH ; Stacy Holzbauer, DVM ; James Meek, MPH ; Zintars G. Beldavs, MS ; L. Clifford Mcdonald, MD ; Scott Fridkin, MD, FSHEA

11:15 AM
Effect of Nucleic Acid Amplification Testing on Population-based Incident Rates of Clostridium difficile Infection (CDI)
Carolyn Gould, MD ; Jonathan Edwards, MStat ; Jessica Cohen, MPH ; L. Clifford Mcdonald, MD ; Monica M. Farley, MD ; Helen Johnston, MPH ; Lucy Wilson, MD ; Samir Hanna, MD ; Lisa Winston, MD ; Stacy Holzbauer, DVM ; Carol Lyons, MPH ; Erin Phipps, DVM ; Gary Hollick, PhD ; Zintars G. Beldavs, MS ; Dale Gerding, MD, FIDSA ; Fernanda Lessa, MD

11:30 AM
The Biology and Epidemiology of Clostridium difficile in Oxfordshire Hospitals 2007-2010
Madeleine Cule, PhD ; Rory Bowden, PhD ; David Eyre, BM, BCh ; A. Sarah Walker, PhD ; David Griffiths, BSc ; John Finney ; David Wyllie, PhD ; Derrick Crook, MB, BCh ; Tim Peto, MB BS, DPhil ; Peter Donnelly

11:45 AM
Prevalence and Risk Factors for Asymptomatic Clostridium difficile Carriage
Erik Dubberke, MD, MSPh ; Faisal Alasmari, MD ; Sondra Seiler, BA ; Tiffany Hink, BS ; Carey-Ann Burnham, PhD

CME Credits:

Disclosures:

E. Dubberke, Optimer: Consultant, Grant Investigator and Speaker's Bureau, Consulting fee, Research support and Speaker honorarium
Pfizer: Consultant, Consulting fee
Merck: Consultant and Investigator, Consulting fee and Research support
Sanofi Pasteur: Consultant, Consulting fee
Viropharma: Investigator, Research support

K. Carroll, BD Diagnostics, Inc: Grant Investigator, Research support
Quidel Inc.: Scientific Advisor, Consulting fee
NanoMR: Scientific Advisor, Consulting fee
Roche Molecular: Consultant, Consulting fee

See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 17th with the exception of research findings presented at the IDWeek press conferences.